10b5-1

This Morrison & Foerster alert provides an overview of enforcement trends regarding Rule 10b5-1 plans, discusses the proposed legislative changes to Rule 10b5-1 plans, and advises on best practices for Rule 10b5-1 plans— both as the law currently governs them and in line with anticipated changes.

This memo discusses Tetraphase Pharmaceuticals and other case law regarding the role of 10b5-1 plans, briefly outlines the requirements of 10b5-1 plans, and provides practical reminders to corporations and their counsel on crafting plans that will likely be most successful in shielding corporate executives from liability.This memo discusses Tetraphase Pharmaceuticals and other case law regarding the role of 10b5-1 plans, briefly outlines the requirements of 10b5-1 plans, and provides practical reminders to corporations and their counsel on crafting plans that will likely be most successful in shielding corporate executives from liability.This memo discusses Tetraphase Pharmaceuticals and other case law regarding the role of 10b5-1 plans, briefly outlines the requirements of 10b5-1 plans, and provides practical reminders to corporations and their counsel on crafting plans that will likely be most successful in shielding corporate executives from liability.

This article provides an update in insider trading compliance and the use of Rule 10b5-1 plans. The article discusses best practices for Rule 10b5-1 plans, such as cooling off/waiting periods, time limitations, allowing trades outside of the plan, use of multiple plans, modification/termination of plans, and more.

Learn about the latest best practices in implementing and monitoring 10b5-1 plans.

Increased scrutiny from regulators during the pandemic means extra caution for insiders in trading the company's stock. Learn more about the do's and don'ts of insider trading.

Speculating About 10b5-1 Plans

A checklist for implementing Rule 10b5-1 trading plans.

Due to the continual changes to Section 16 practice resulting from SEC staff interpretations and Section 16(b) litigation, companies and compliance personnel regularly are confronted with new challenges in keeping their advice and their compliance programs up to date. As reflected by the many questions posed daily on the electronic forums of Section16.net and Naspp.com, the issues you face today vary widely in scope and complexity.

Use this checklist to administer (review and process) 10b5-1 plans for your insiders.

This executive summary highlights results from the quick survey on Rule 10b5-1 plans cosponsors by the NASPP, Morgan Stanley, and Shearman & Sterling.

Highlights of the 2017 Domestic Stock Plan Administration Survey, cosponsored by the NASPP and Deloitte Consulting LLP.

Read rule 10b5-1 in entirety.